PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-145 Cr | ₹-157 Cr | ₹-130 Cr | ₹-105 Cr | ₹-22 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-145 Cr |
Mar2024 | ₹-157 Cr |
Mar2023 | ₹-130 Cr |
Mar2022 | ₹-105 Cr |
Mar2021 | ₹-22 Cr |
How is Deferred Tax Assets / Liabilities of PIRAMAL PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-145 Cr | Negative | |
Mar2024 | ₹-157 Cr | Negative | |
Mar2023 | ₹-130 Cr | Negative | |
Mar2022 | ₹-105 Cr | Negative | |
Mar2021 | ₹-22 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹25,547.2 Cr | 0.2% | -11.2% | 1.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,383.0 Cr | 2.6% | -5.1% | -6.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,026.0 Cr | -0.5% | -10.1% | 21.8% | Stock Analytics | |
CIPLA | ₹126,159.0 Cr | 4.7% | 4.8% | -4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 0.6% | 5.2% | 8.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,536.0 Cr | 4.3% | -0.7% | -11.4% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 0.2% |
-11.2% |
1.9% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses